No Data
BofA Securities Initiates Moderna(MRNA.US) With Sell Rating, Announces Target Price $41
BofA Downgrades Moderna, Says It's 'Tough Time' to Be Vaccine Maker
BofA Restarts Coverage of 11 Large-cap Biopharmas
Moderna Options Spot-On: On December 10th, 84,390 Contracts Were Traded, With 683.81K Open Interest
Market Falls Wednesday, but Googles Chip Impresses | WST
FDA Highlights Safety Challenges And Development Needs For Pediatric RSV Vaccines Amid Historical Concerns And Recent MRNA Trial Pauses; Focus On Addressing Unmet Needs For Infants And Toddlers.
EZ_money : Bloomberg is pure liberal media propaganda
complete 
media